O cclusive arteriopathies, such as coronary artery and peripheral artery disease, are a consequence of atherosclerosis-related neointima formation involving maladapted migration and proliferation of smooth muscle cells (SMCs). As vascular SMCs are not terminally differentiated, they exhibit substantial plasticity in phenotypic modulation that can be activated on a vascular insult. 1, 2 Members of the Notch family can regulate SMC plasticity and have been associated with neointima formation. [3] [4] [5] [6] [7] The Notch family encompasses an evolutional highly conserved intercellular signaling pathway known to regulate cell fate decision (ie, apoptosis, proliferation, differentiation, and migration) 8 in the cardiovascular system. 9, 10 This family consists of 4 Notch receptors (Notch1 to Notch4) and 2 ligand groups, Jagged (Jagged1, Jagged2) and Delta-like (Dll1, Dll3, Dll4). Both receptors and ligands are transmembrane proteins containing an extracellular domain with which they facilitate communication between cells. After binding of the ligand to the receptor-present on adjacent cells-a proteolytic cascade is activated involving the ␥-secretase/A disintegrin and metalloprotease complex. Cleavage of the intracellular part of the receptor results in the release of the Notch intracellular domain that translocates to the nucleus and, together with its cotranscription factor CBF1/RBPJk, Su(H), Lag1 (CSL), induces the transcription of the basic helix-loop-helix transcription factors hairy/enhancer of split (HES) and hairy enhancer of split-related repressor protein (HERP). [11] [12] [13] Also, the ligand is cleaved on receptor interaction by the same proteases, giving rise to a soluble extracellular ligand domain that can influence NOTCH signaling as well. 14 For example, soluble Jagged1 (sJag1) inhibits migration and proliferation of the fibroblast cell line NIH3T3. 15, 16 Notch1, Notch3, and Jagged1, along with the downstream HES/HERP proteins, are expressed in adult SMCs. 17 Jagged1 and Notch1 play important, nonredundant roles during vascular development, as their respective knockouts die early in utero because of vascular remodeling defects of the yolk sac. 18, 19 Notch3 mutants are viable and fertile but present with structural vascular defects showing reduced arterial size and deficient SMC differentiation postnatally (ie, low SM22␣ and smoothelin expression), 20,21 suggesting a function of Notch3 in vascular maturation. A role for Notch3 in arterial maturation is also supported by the phenotype of NOTCH3 mutations in men (ie, cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy). 22 In vitro experiments by Sweeney et al underline this notion further, showing that constitutive expression of Notch1/3 intracellular domain in SMCs increased proliferation and inhibited apoptosis. 6 Consistently, Jagged1 increased the expression of smooth muscle-myosin heavy chain, 23 whereas the Notch downstream transcription factors HERP1 and HERP2 were able to stimulate SMC migration, proliferation, 9 and differentiation. 24 -26 As migration of SMCs is a prerequisite for neointima formation after arterial injury, we hypothesized that blockage of Notch signaling with sJag1 could reduce neointima formation. Here, we show that neointima formation in a balloon injury carotid rat artery model was inhibited by sJag1. Accordingly, sJag1 was able to reduce the SMC proliferation and migration capacity by interfering with Notch signaling involving depression of Herp2 expression.
Methods
A detailed description of methods can be found in the supplemental materials, available online at http://atvb.ahajournals.org.
Statistical Analysis
For intergroup comparison, 1-way ANOVA with Tukey post hoc test using SPSS software (version 12.0) was applied. Values are expressed as meanϮSEM. Probability values of Ͻ0.05 were considered significant.
Results

Notch1, Notch3, Jagged1, and Herp2 Were Highly Expressed in Injured Arteries
The expression of Notch1, Notch3, Jagged1, and Herp2 in intact and injured carotid arteries was determined at day 3 (early stage injury response) and day 14 (late stage injury response) postinjury by immunohistochemistry and was compared with shams ( Figure 1 ). On injury, neointima formation progressed rapidly over time, beginning at day 3 and showing a profound and cell rich neointima at day 14 postinjury (intima to media ratio, Ͼ1.7). This injury response was associated with clear spatial-temporal changes in the expression of Notch members.
In noninjured carotid arteries, the Notch receptors ( Figure  1A) were differentially expressed, with Notch1 being present throughout the vessel wall but more pronounced in the endothelium. Notch3 was expressed at a much lower level, with moderate presence in the media and relative high signal in adventitial myofibroblasts. Jagged-1 was heterogeneously expressed, with relative low levels in the intima and with individual cells containing a higher protein content in the media and adventitia. For Herp2, a relative low and scattered expression was apparent for the vessel wall, with a higher level for the adventitia.
Three days after injury ( Figure 1B ), Notch1 was reduced throughout the wall with exception of the periadventitial layer of SMCs. In contrast, Notch3 was increased in the injured media, as well as the adventitia, with a typical high expression in the periendothelial SMC layer. Jagged-1 and Herp2 expression was also increased with a prominent signal in the periendothelial SMCs and adventitia, overlapping the Notch3 expression pattern. At day 14, the cell-rich neointima ex-pressed all Notch members more strongly than the media and adventitia ( Figure 1C ). At this stage, the expression of Herp2 remained high, reflecting a considerable degree of Notch signaling in the injured vessel wall. Interestingly, the vasa vasorum surrounding the vessel were highly Notch positive (not shown).
sJag1 Negatively Affected the Proliferation and Migration of SMCs
To define the potential effects of sJag1 on endothelial cell (EC) and SMC behavior, both primary cell types were transduced with adenoviral vectors for sJag1 (Ad-sJag1), full-length Jag1 (Ad-Fl-Jag1), or LacZ (Ad-LacZ, control), cultured and subsequently analyzed for their migratory and proliferative capacity ( Figure 2 ). Standard microscopy on cell morphology and viability revealed no confounding cytotoxicity. Transduction efficiency was established by Western Blotting for c-myc and Jagged-1 on protein extracts from coronary artery smooth muscle cells (CASMCs) and human umbilical endothelial cells (HUVECs) that were infected with Ad-sJag1 and Ad-Fl-Jag1, respectively, or Ad-LacZ as control. All infected cells revealed clear increased expression of the protein of interest compared with the LacZ control ( Figure 2E and 2F and Supplemental Figure IIB) . Figure 1 . Notch1, Notch3, Jagged1, and Herp2 expression in noninjured (0 days, A) and injured carotid arteries at 3 days (B) and 14 days (C) following injury. Shown are high-magnification images of cross-sections with similar orientations, ie lumen to the right and adventitia (A) to the left. A, At 0 days, Notch1 (N1) was expressed throughout the vessel wall but especially in the endothelium (arrowheads). Notch3 (N3) was barely detectable in the media. Only adventitial myofibroblasts expressed N3 at a high level (arrows). Jagged-1 (Jag1) and Herp2-expression was found in the vessel wall. B, At 3 days, N1 expression was reduced, and N3 was increased, showing a high content in adventitia and the more luminal SMC layers (arrowheads). Also, Jag-1 and Herp2 were present in the wall, Jag-1 was expressed by all SMCs, and the Herp2 pattern highly resembled that of N3. C, 14 days after injury, the neointima layer (*) abundantly expressed all Notch members.
Ad-sJag1, but not Ad-Fl-Jag, considerably reduced migration of CASMCs (Figure 2A ; sJag1, 6701Ϯ227 relative fluorescence units; LacZ, 11 986Ϯ557 relative fluorescence units; Fl-Jag, 13 240Ϯ1053 relative fluorescence units; PϽ0.01). Ad-sJag1 also significantly depressed the proliferation of CASMCs compared with Ad-LacZ-and Ad-Fl-Jag1infected cultures at both 48 hours posttransduction ( Figure  2C , ratio to 24 hours: 1.34Ϯ0.024 versus 1.67Ϯ0.051 and 1.63Ϯ0.077, respectively, PϽ0.01) and 72 hours posttransduction (1.60Ϯ0.059 versus 2.08Ϯ0.024 and 2.02Ϯ0.10, respectively, PϽ0.01). In contrast, migration and proliferation of HUVECs were unaffected by Ad-sJag1 or Ad-Fl-Jag ( Figure 2B and 2D). A comparable lack of effect was also obtained with human coronary artery ECs (data not shown). Interestingly, Lindner et al 16 reported that NIH3T3 cells stably transfected with sJag1 migrated at a slower rate than cells transfected with a control vector. However, when cells were cultured on a fibronectin substrate, this phenotype was partially rescued. To rule out matrix dependency of sJaginduced effects, we therefore tested the migration capacity of Ad-LacZ and Ad-sJag1 infected HUVECs that were cultured on fibronectin or plastic, but we were unable to detect a difference (Supplemental Figure IA 
sJag1 Reduced Neointima Formation
To determine the effect of sJag1 on the development of neointima formation, injured carotid arteries were instilled with Ad-sJag1, Ad-Fl-Jag1 or Ad-LacZ control. In vivo efficiency defined by X-Gal staining of Ad-LacZ infected day 3 postinjury rat carotid arteries was sufficient (Supplemental Morphometric analysis was performed on carotid artery cross-sections 14 days after injury that were infected with Ad-sJag1, Ad-Fl-Jag1, or Ad-LacZ. Neointima formation in control Ad-LacZ-treated carotid arteries was comparable to that of injured nontransduced carotid arteries, excluding cytotoxic effects of the viral intervention in vivo (data not shown). In accordance with the observed in vitro reduction in SMC proliferation and migration, Ad-sJag treatment resulted in more than 40% (1.02Ϯ0.19) reduction in intima/media ratio compared with the control and Ad-Fl-Jag1 (1.74Ϯ0.18 and 1.73Ϯ0.14, respectively; PϽ0.01) ( Figure 3A and 3B ). Immunohistochemical staining against proliferating cell nuclear antigen (PCNA) was performed to examine the effect of sJag1 on SMC proliferation in vivo. The SMCs proliferative index at 3 days (calculated as the percentage of positive cells among total nucleated cells) was significantly lower in the media of injured carotid arteries from Ad-sJag1 group compared with Ad-LacZ group (40Ϯ8% versus 28.7Ϯ4.2%, PϽ0.05; Figure 3C ). No difference in SMC proliferation rate between treatments was observed at 14 days after injury. A significantly higher degree of reendothelialization was apparent for the Ad-sJag1-treated group after 14 days, whereas the Ad-Fl-Jag1-treated group did not differ from the control (92.4Ϯ1.0% versus 81Ϯ3.3% and 83Ϯ4.4%; Figure 3E ; en face staining, Figure 3D ).
Expression analysis of Notch members in the adenovirustreated groups revealed no clear differences in expression of Notch1 at days 3 and 14 day postinjury. As expected, Jag1 was expressed more highly in the Ad-Fl-Jag1-treated group at 
Notch Related Herp2 Signaling in Neointima Formation and SMC Function
Treatment of injured carotid arteries with Ad-sJag1 resulted in a sharp decrease in medial expression of the Notch target gene Herp2 3 days after injury ( Figure 4A Figure VIA) .
The inhibitory effect of sJag1 on Herp2 expression was further assessed in vitro. CASMCs treated with 5 g/mL of sJag1 recombinant protein or infected with Ad-sJag1 decreased Herp2 expression ( Figure 4B , right and left). Conversely, CASMCs infected with Ad-Fl-Jag1 showed increased Herp2 expression (Supplemental Figure VIB) .
The functional relevance of sJag1-inhibited Herp2 for the migration and proliferation of SMC was studied by a rescue experiment in which Herp2 was overexpressed. As expected, sJag1 gave a strong reduction in SMC migration in comparison with mock-treated control for all time points analyzed ( Figure 4C ). At 24 hours, a difference of more than 10-fold between control and sJag1-treated control was apparent (8.8% versus 100%). This depressed SMC migratory capacity could partially be rescued by inducing Herp2 expression (52.5% after 24 hours), indicating that Notch-Herp2 signaling is involved in SMC migration. Similarly, the negative effect of sJag1 on CASMC proliferation was abrogated by Herp2 overexpression (Figure 4D ). sJag1 treatment, at 72 hours posttransfection, resulted in a significant reduction of SMC proliferation compared with the untreated, mock condition (Ctrl) ( Figure 4D , ratio to 24 hours sJag1, 1.78Ϯ0.031; control, 2.37Ϯ0.002; PϽ0.001). Herp2 overexpression was able to rescue SMC proliferation of the sJag1-treated samples (Herp2ϩsJag1, 2.65Ϯ0.018; sJag1, 1.78Ϯ0.031; PϽ0.001), and it increased the proliferation in untreated cells (Herp2, 3.22Ϯ0.005; control, 2.37Ϯ0.002; PϽ0.001).
Discussion
In this study, we present evidence that sJag1 effectively inhibits neointima formation on vascular injury through attenuation of Notch signaling and subsequent reduction of SMC proliferation and migration.
The development of intimal hyperplasia is associated with a temporal spatial change in Notch1, Notch3, Jagged1, and Herp2. As early as 3 days postinjury, a clear upregulation of Notch3, Jagged1, and Herp2 was obvious for the vessel wall, indicating a quick induction of Notch expression and activation on insult at the locus of neointima formation. The upregulation of Notch members is in agreement with previously published data. 4, 16 However, 2 studies 27,25 have reported a downregulation of Notch members at the mRNA and protein level 27 or low levels of Herp2 expression 25 during the early phases of vessel remodeling. This discrepancy most likely relates to the region of the injured vessel examined, as we focused on the border zone of the regenerating endothelium and midsections, whereas others analyzed the mRNA and protein content of the entire vessel 27 or studied the aorta. 25 Neointima formation is considered the result of excessive SMC proliferation and migration that can be regulated and contained by regenerating endothelium. 28, 29 The marked upregulation of Jagged and Notch expression in the regenerating endothelium and underlying media of balloon-injured rat carotid arteries point toward a localized Notch signaling circuitry that is activated on vascular injury. The positive role of Notch signaling in SMC proliferation and migration has been shown in models of constitutive overexpression of intracellular Notch1 and Notch3. 6 Consistently, abrogated Notch signaling in hemizygous Notch1 and Herp1 knockouts reduced SMC proliferation and migration, as well as neointima formation. 4, 30 Moreover, sJag1 is known to interfere with Notch signaling 31, 14 and to reduce cell migration and proliferation of NIH3T3 fibroblastic cells. 16 We showed that sJag1 is able to diminish SMC migration and proliferation in vitro. Accordingly, proliferation of SMCs was reduced in the media of carotid artery from Ad-sJag1 group at day 3 compared with the Ad-LacZ group.
In vivo reendothelialization was slightly increased at 14 days after vascular injury, whereas sJag1-treated ECs in vitro revealed no obvious changes in proliferation or migration. In view of the small in vivo difference found and the lack of a clear effect in vitro, it is unlikely that sJag1 plays a major role in endothelial regeneration. It is worth noting that Jag1 appears to be the main ligand for vascular SMCs related Notch signaling, 23 whereas DLL4 has been reported the major inducer of NOTCH activation in EC. 32, 33 Accordingly, we show that stimulation of ECs with immobilized recombinant DLL4 increased the expression of the Notch target genes HES1, HERP1, HERP2, and HERP3 (Supplemental Figure  VII) . 34 Conversely, stimulation with immobilized recombinant Jag1 had no effect on these Notch target genes in ECs except for HERP2. Nonetheless, this increase in HERP2 expression following recombinant Jag1 stimulation was far less profound than after recombinant DLL4 stimulation (Supplemental Figure VII) . Thus, other Notch ligands, beyond Jagged1, are likely involved in regulating endothelial regeneration following vascular injury, with DLL4 being a possible candidate. Lindner et al 16 showed a matrix protein dependency of sJag1 effects on NIH3T3. Specifically, NIH3T3 migrated at a much slower rate than cells transfected with vector control when seeded on plastic, but on fibronectin, this effect was much reduced. Therefore, we tested the effect of fibronectin coating on the migration and proliferation of EC in presence of sJag1. We found that HUVECs cultured on fibronectin failed to respond to sJag1 as HUVECs cultured on plastic did, indicating that the lack of effect of sJag1 on EC function is not related to the coating used.
From in vitro and in vivo studies, it has become evident that both Herp1 and Herp2 act downstream of the Notch/ intracellular domain signaling, 35, 36 regulate SMC differentiation and migration, and stimulate vascular remodeling in response to trauma. [3] [4] [5] [6] [7] In a previous study, the Notch1-Herp1 axis was reported to stimulate vascular SMC proliferation and migration in vitro and neointimal formation in rodents after vascular injury. 3, 4, 25 In accordance, we observed upregulation of Herp2 expression in the media and neointima of injured vessels, which was reduced in injured vessels treated with sJag1. In vitro, Ad-sJag1 infection or recombinant sJag1 stimulation reduced Herp2 mRNA expression in SMCs, suggesting an inhibitory effect on Notch signaling. The observation that the hampered migration and proliferation of the sJag-treated SMCs could be partially rescued by Herp2 overexpression suggests that Notch-Herp2 signaling is required for SMC function and that sJag is inhibitory. Considering the overlap in expression and function between Herp1 and Herp2 in cardiovascular development and SMC function, together with our data, it can be concluded that Herp2 plays a role in neointima formation as well.
Notch signaling has been reported to promote SMC differentiation. 23, 26 Recently, Liu et al 5 demonstrated that Jag1induced Notch3 signaling initiates an autoregulatory loop that results in Notch3 overexpression and simultaneously enhanced the expression of SMC markers, such as ␣SMA, CALPONIN, and smooth muscle-myosin heavy chain. We also showed that Notch3 expression in carotid artery sections in the Ad-sJag1 group was reduced concomitant with SMC marker ␣SMA expression at day 3, confirming the positive role of Notch in regulating SMC differentiation. In contrast, other studies have shown that NOTCH can negatively affect SMC differentiation by interfering with serum response factor and myocardin, 7,25 both of which are essential for the expression of SMC markers. The apparent conflict in the data likely relates to the balance between Notch intracellular domain/RBPkJ 7 and Notch target genes (Herp1 and Herp2) 37 that can induce and inhibit SMC differentiation, respectively.
In conclusion, we report that sJag1 inhibits neointima formation in a rat carotid artery injury model by interfering with Notch-Herp2 signaling. The sJag1 inhibitory effect on Notch activation is likely related to its interference with membrane-bound, ligand-induced signaling. Notch ligands induce signaling only when expressed on the cell surface or immobilized to a substrate, 31, 37 whereas they show no activity or antagonistic activity when expressed as soluble forms. 31, 37, 38 Here, we describe an interesting approach to reduce neointima formation by blocking Notch signaling with sJag1, providing a potentially applicable clinical tool for lowering the risk of restenosis in patients with peripheral artery disease.
